We serve Chemical Name:Isosakuranetin CAS:480-43-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Isosakuranetin
CAS.NO:480-43-3
Synonyms:iso-Sakuranetin;5,7-DIHYDROXY-4′-METHOXYFLAVANONE;Isosakurametin;4′-Methylnaringenin;Citrifoliol;4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-methoxyphenyl)-, (2S)-;Isosakuranetin;Kikokunetin;Angophorol;(2S)-5,7-Dihydroxy-2-(4-methoxyphenyl)-2,3-dihydro-4H-chromen-4-one;naringenin 4′-methyl ether;isokaurentin;4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-methoxyphenyl)-, (S)-;4′-methoxy-5,7-dihydroxyflavanone
Molecular Formula:C16H14O5
Molecular Weight:286.279
HS Code:29329990
Physical and Chemical Properties:
Melting point:193-194ºC
Boiling point:539.2±50.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.638
PSA:75.99000
Exact Mass:286.084137
LogP:3.84
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like iso-Sakuranetin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4′-methoxy-5,7-dihydroxyflavanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Kikokunetin Use and application,4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-methoxyphenyl)-, (2S)- technical grade,usp/ep/jp grade.
Related News: Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. hydrogenselenite manufacturers In the trial, 362 eligible patients were randomised (1:1) and received a fixed-dose intravenous infusion of 300mg anifrolumab or placebo every four weeks. magnesium,strontium,phosphonato phosphate suppliers ICER’s researchers used a two-year treatment horizon in their model but noted that it’s unclear how long patients are supposed to remain on these treatments. The model may not fully capture the challenges the disease presents to patients, ICER acknowledged. L-Phenylalanine,N-[[3-fluoro-4′-[2-(phenylmethyl)-3-benzofuranyl][1,1′-biphenyl]-4-yl]sulfonyl]-N-methyl- vendor & factory.
